Compare HALO & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | NXE |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.2B |
| IPO Year | N/A | N/A |
| Metric | HALO | NXE |
|---|---|---|
| Price | $68.77 | $9.27 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $73.33 | N/A |
| AVG Volume (30 Days) | 2.3M | ★ 7.6M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $1,242,852,000.00 | N/A |
| Revenue This Year | $34.83 | N/A |
| Revenue Next Year | $24.84 | N/A |
| P/E Ratio | $14.54 | ★ N/A |
| Revenue Growth | ★ 31.19 | N/A |
| 52 Week Low | $47.00 | $3.91 |
| 52 Week High | $79.50 | $9.99 |
| Indicator | HALO | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 54.80 |
| Support Level | $61.23 | $8.14 |
| Resistance Level | $69.28 | $9.66 |
| Average True Range (ATR) | 1.69 | 0.44 |
| MACD | 0.69 | 0.03 |
| Stochastic Oscillator | 93.54 | 73.34 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.